NCT00295100View on ClinicalTrials.gov

Tamoxifen-MRI Study

PHASE2CompletedINTERVENTIONAL

Enrollment

78

Participants

Timeline

Start Date

September 30, 2000

Study Completion Date

July 31, 2006

Conditions

Breast Cancer

Interventions

DRUG

Tamoxifen

Trial Locations (7)

19104

University of Pennsylvania, Philadelphia

19111

Fox Chase Cancer Center, Philadelphia

48201

Wayne State University, Detroit

55905

Mayo Clinic, Rochester

90095

UCLA Medical Center, Los Angeles

02115

Dana Farber Cancer Institute, Boston

Unknown

European Institute of Oncology, Milan

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

collaborator

AstraZeneca

INDUSTRY

lead

University of Pennsylvania

OTHER